Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04682977 · ClinicalTrials.gov registry record · NA

Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline

A NA study of Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) and Uncontrolled Diabetes (HBA1c ≥ 10), sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT04682977 is a NA study of Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) and Uncontrolled Diabetes (HBA1c ≥ 10) that has completed, run by University of Illinois at Chicago. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04682977, a NA study of Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) and Uncontrolled Diabetes (HBA1c ≥ 10), has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.

Interventions

  • OTHER IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning)
  • OTHER Usual primary care services

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2021-08-11
Est. Completion 2024-03-01
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT04682977

The ClinicalTrials.gov registry entry for NCT04682977 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) appearing as the primary indexed condition, and to 2 interventions - of which IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) is the first listed.

NCT04682977 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04682977 about?

NCT04682977 is a clinical study titled "Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline". Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.

What is the current status of trial NCT04682977?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2021-08-11. Estimated completion is 2024-03-01.

What conditions does trial NCT04682977 study?

This clinical trial studies the following conditions: Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease), Uncontrolled Diabetes (HBA1c ≥ 10).

What interventions are being tested in trial NCT04682977?

The interventions under investigation include: IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) (OTHER), Usual primary care services (OTHER).

Who is sponsoring clinical trial NCT04682977?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04682977 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.